Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,115 | 42 | 94.9% |
| Education | $60.00 | 1 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $355.63 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $214.63 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $188.12 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $113.88 | 5 | $0 (2024) |
| Novo Nordisk Inc | $86.34 | 4 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $37.95 | 1 | $0 (2024) |
| Eisai Inc. | $32.36 | 1 | $0 (2024) |
| Inspire Medical Systems, Inc. | $32.32 | 1 | $0 (2024) |
| PFIZER INC. | $32.11 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $31.47 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $980.78 | 34 | AstraZeneca Pharmaceuticals LP ($355.63) |
| 2023 | $194.46 | 9 | GlaxoSmithKline, LLC. ($112.55) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: PAIN | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $60.00 | General |
| 09/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: Neurology | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Biological | ||||||
| 08/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: NEUROLOGY | ||||||
| 07/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Gastroenterology | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: Biological | ||||||
| 06/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardio-renal | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: PSYCHIATRY | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 117 | 151 | $25,987 | $12,350 |
| 2022 | 5 | 195 | 215 | $45,640 | $12,392 |
| 2021 | 8 | 306 | 345 | $58,559 | $16,486 |
| 2020 | 5 | 244 | 262 | $39,858 | $10,618 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 33 | 57 | $9,975 | $5,115 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 41 | $6,437 | $2,540 | 39.5% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 16 | 16 | $3,600 | $2,093 | 58.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 17 | $2,975 | $1,531 | 51.5% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 18 | 20 | $3,000 | $1,070 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 98 | $30,674 | $7,284 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $8,928 | $3,567 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 20 | $4,220 | $955.43 | 22.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $882.00 | $431.20 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 41 | 52 | $936.00 | $153.90 | 16.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 107 | $33,491 | $8,165 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $11,808 | $4,825 | 40.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 35 | $7,385 | $1,686 | 22.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 55 | 55 | $2,585 | $921.25 | 35.6% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 12 | 12 | $720.00 | $359.28 | 49.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 54 | 72 | $1,296 | $216.00 | 16.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $756.00 | $214.32 | 28.3% |
| 69209 | Removal of impacted ear wax by washing | Office | 2021 | 11 | 11 | $517.50 | $99.18 | 19.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 37 | 37 | $10,656 | $3,831 | 36.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 53 | $16,589 | $3,752 | 22.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 43 | $9,073 | $2,089 | 23.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 42 | 42 | $1,974 | $686.07 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 73 | 87 | $1,566 | $259.44 | 16.6% |
About Pratima Patil, NP
Pratima Patil, NP is a Family healthcare provider based in Auburn, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1881141802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Pratima Patil, NP has received a total of $1,175 in payments from pharmaceutical and medical device companies, with $980.78 received in 2024. These payments were reported across 43 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,115).
As a Medicare-enrolled provider, Patil has provided services to 862 Medicare beneficiaries, totaling 973 services with total Medicare billing of $51,845. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Auburn, MA
- Active Since 09/07/2016
- Last Updated 09/15/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881141802
Products in Payments
- FARXIGA (Drug) $293.33
- TRELEGY ELLIPTA (Drug) $188.12
- Veozah (Drug) $154.63
- XIFAXAN (Drug) $113.88
- BREZTRI (Drug) $62.30
- Wegovy (Drug) $44.53
- OPSUMIT (Drug) $37.95
- Leqembi (Drug) $32.36
- INSPIRE (Device) $32.32
- NURTEC ODT (Drug) $32.11
- LEQVIO (Drug) $31.47
- CAPLYTA (Drug) $30.76
- Ozempic (Drug) $20.97
- Rybelsus (Drug) $20.84
- Kerendia (Drug) $19.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Auburn
Molly Reeves
Family — Payments: $158,223
Jodi Strock, Np-C, NP-C
Family — Payments: $15,991
Catherine Kohl
Family — Payments: $8,838
Kaylin Garnett, Crnp, Fnp-Bc, CRNP, FNP-BC
Family — Payments: $6,862
Ehren Gleckler
Family — Payments: $6,853
Trisha Smith, Aprn, APRN
Family — Payments: $5,011